Premium
[ 18 F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer
Author(s) -
Zee Sygrid,
Vállez García David,
Elsinga Philip H.,
Willemsen Antoon T.M.,
Boersma Hendrikus H.,
Gerritsen Marleen J.J.,
Spikman Jacoba M.,
Laar Teus
Publication year - 2019
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.27698
Subject(s) - positron emission tomography , parkinson's disease , nuclear medicine , medicine , tracer , positron emission , central nervous system disease , physics , disease , pathology , nuclear physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom